Investigating Visual Verticality Disorder and Lateropulsion in a Neurosurgical Cohort of Patients With Brain Tumours
Trial Parameters
Brief Summary
The overall objective of this research is to investigate the clinical characteristics pre- and post-brain tumour resection with a focus on visual verticality disorder, and lateropulsion, including neuroimaging analysis, of a neurosurgical cohort of patients with brain tumours. This prospective observational cohort study will investigate clinical and neuroimaging characteristics and the relationship between lateropulsion and visual verticality disorder in patients pre- and post-brain tumour resection. Patients (aged 18-80 years, with a confirmed diagnosis of brain tumour and a neurosurgical pathway) will be enrolled from the state-wide Neurosurgery Service of Western Australia at Sir Charles Gairdner Hospital.
Eligibility Criteria
Inclusion Criteria: * Patients of age 18 to 80 admitted to SCGH under the neurosurgery team with a confirmed diagnosis of a brain tumour. * Only patients who undergo partial or full brain tumour resection and are medically stable. * Able to provide written informed consent or consent provided by a Research Decision-Maker with the approval of an Independent Medical Practitioner (IMP) as per the Guardianship and Administration Act 1990 (GAA). * Patients with a support network that enables them to accommodate to travel commitments for assessments if travel to the hospital is required. Exclusion Criteria: * Patients who undergo only biopsy will not be included. * Unable to follow any instructions and complete assessments due to significant medical deterioration. * Patients who are pregnant. * Current diagnosis of COVID-19 or respiratory syncytial virus (RSV), or any type of influenza. * Patients without a support network that enables them to accommodate to travel commitments for assessment